Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 158, Issue 6, Pages 1442-1453Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1476-5381.2009.00411.x
Keywords
acute lung injury; protein oxidation; hydrogen sulphide; smoke inhalation; sheep
Categories
Funding
- National Institute for General Medical Sciences [GM66312]
- Shriners of North America and Ikaria Inc. (Seattle, WA, USA) [8954, 8450, 8460]
Ask authors/readers for more resources
Background and purpose: The present study investigated whether the pathophysiological changes induced by burn and smoke inhalation are modulated by parenteral administration of Na2S, a H2S donor. Experimental approach: The study used a total of 16 chronically instrumented, adult female sheep. Na2S was administered 1 h post injury, as a bolus injection at a dose of 0.5 mg center dot kg-1 and subsequently, as a continuous infusion at a rate of 0.2 mg center dot kg-1 center dot h-1 for 24 h. Cardiopulmonary variables (mean arterial and pulmonary arterial blood pressure, cardiac output, ventricular stroke work index, vascular resistance) and arterial and mixed venous blood gases were measured. Lung wet-to-dry ratio and myeloperoxidase content and protein oxidation and nitration were also measured. In addition, lung inducible nitric oxide synthase expression and cytochrome c were measured in lung homogenates via Western blotting and enzyme-linked immunosorbent assay (elisa) respectively. Key results: The H2S donor decreased mortality during the 96 h experimental period, improved pulmonary gas exchange and lowered further increase in inspiratory pressure and fluid accumulation associated with burn- and smoke-induced acute lung injury. Further, the H2S donor treatment reduced the presence of protein oxidation and 3-nitrotyrosine formation following burn and smoke inhalation injury. Conclusions and implications: Parenteral administration of the H2S donor ameliorated the pulmonary pathophysiological changes associated with burn- and smoke-induced acute lung injury. Based on the effect of H2S observed in this clinically relevant model of disease, we propose that treatment with H2S or its donors may represent a potential therapeutic strategy in managing patients with acute lung injury.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available